DSCM
CRMD icon

Del-Sette Capital Management’s CorMedix CRMD Stock Holding History

Del-Sette Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-210,831
Closed -$2.45M – 48
2025
Q4 		$2.45M Buy
+210,831
New +$2.33M 1.51% 24

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Del-Sette Capital Management's CRMD Position: Q1 2026 in Review

Del-Sette Capital Management sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 210,831 shares — an estimated $2.45M sold.

Del-Sette Capital Management first reported a position in CRMD in Q4 2025 and held it in 1 quarter. The position peaked at $2.45M in Q4 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Del-Sette Capital Management reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Del-Sette Capital Management sold 210,831 CorMedix shares in Q1 2026, an estimated $2.45M.
  • Del-Sette Capital Management first reported a position in CorMedix in Q4 2025 and held it in 1 quarter.
  • Del-Sette Capital Management's CorMedix position peaked at $2.45M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Del-Sette Capital Management's 13F filing for Q1 2026, filed 4 May 2026.